Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Mas

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
JTCVS Open|December 31, 2025
Regadenoson in the rehabilitation of marginal donor lungs on ex vivo lung perfusion: A blinded multicenter randomized controlled clinical trialEmily Fleischmann, Mark Conaway, Joseph Rabin, et al.
International Journal of Molecular Sciences|June 2, 2021
Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion InjuryMaria Namwanje, Bijay Bisunke, Thomas V Rousselle, et al.
Plos One|May 29, 2019
Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate MofetilOpas Traitanon, James M Mathew, Aneesha Shetty, et al.
Kidney International|October 30, 2014
Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimusLorenzo Gallon, Opas Traitanon, Nedjema Sustento-Reodica, et al.
Transplantation|January 19, 2011
Gene expression changes are associated with loss of kidney graft function and interstitial fibrosis and tubular atrophy: diagnosis versus predictionMariano J Scian, Daniel G Maluf, Kellie J Archer, et al.
Transplantation Direct|November 18, 2020
Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic SteatohepatitisSanjaya K Satapathy, Pratik Banerjee, Joseph F Pierre, et al.
Clinical and Translational Gastroenterology|February 8, 2021
Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver TransplantationSanjaya K Satapathy, Quynh T Tran, Alexander J Kovalic, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 13, 2020
The Fourth International Workshop on Clinical Transplant ToleranceFadi Issa, Samuel Strober, Joseph R Leventhal, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Shroom3-Rock interaction and profibrotic function: Resolving mechanism of an intronic CKD risk alleleAnand Reghuvaran, Ashwani Kumar, Qisheng Lin, et al.
Nature Communications|December 30, 2025
Design of precision therapeutics for a CKD risk allele by targeting Shroom3-Rock interactionAnand Reghuvaran, Ashwani Kumar, Qisheng Lin, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
JTCVS Open|December 31, 2025
Regadenoson in the rehabilitation of marginal donor lungs on ex vivo lung perfusion: A blinded multicenter randomized controlled clinical trialEmily Fleischmann, Mark Conaway, Joseph Rabin, et al.
International Journal of Molecular Sciences|June 2, 2021
Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion InjuryMaria Namwanje, Bijay Bisunke, Thomas V Rousselle, et al.
Plos One|May 29, 2019
Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate MofetilOpas Traitanon, James M Mathew, Aneesha Shetty, et al.
Kidney International|October 30, 2014
Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimusLorenzo Gallon, Opas Traitanon, Nedjema Sustento-Reodica, et al.
Transplantation|January 19, 2011
Gene expression changes are associated with loss of kidney graft function and interstitial fibrosis and tubular atrophy: diagnosis versus predictionMariano J Scian, Daniel G Maluf, Kellie J Archer, et al.
Transplantation Direct|November 18, 2020
Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic SteatohepatitisSanjaya K Satapathy, Pratik Banerjee, Joseph F Pierre, et al.
Clinical and Translational Gastroenterology|February 8, 2021
Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver TransplantationSanjaya K Satapathy, Quynh T Tran, Alexander J Kovalic, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 13, 2020
The Fourth International Workshop on Clinical Transplant ToleranceFadi Issa, Samuel Strober, Joseph R Leventhal, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Shroom3-Rock interaction and profibrotic function: Resolving mechanism of an intronic CKD risk alleleAnand Reghuvaran, Ashwani Kumar, Qisheng Lin, et al.
Nature Communications|December 30, 2025
Design of precision therapeutics for a CKD risk allele by targeting Shroom3-Rock interactionAnand Reghuvaran, Ashwani Kumar, Qisheng Lin, et al.
Pageof 4